Driving CAR T cell translation forward

L Schultz, C Mackall - Science translational medicine, 2019 - science.org
… responses have been achieved using CAR T cells targeting CD19, a B cell antigen with
conserved expression by the majority of B cell malignancies. The success of CD19-CAR T …

[引用][C] Cancer immunotherapy utilizing iPS cell-derived macrophages.

S FUKUSHIMA - 月刊腫瘍内科, 2023 - jglobal.jst.go.jp
… *induced pluripotent stem cell About induced pluripotent stem celliPSC-Derived
Natural Killer Cell Therapies - Expansion and …

[HTML][HTML] High-density culturing of the dermal fibroblast cells on hydrogel-based soft microcarriers for cell therapy application

A Seyfoori, E Askari, M Razzaghi, MH Karimi… - Chemical Engineering …, 2024 - Elsevier
cell manufacturing systems hold significant importance in influencing the behavior of
target cells… size on various cellular characteristics of HDFs, including cell attachment, gene …

[HTML][HTML] Tropomyosin 1 deficiency facilitates cell state transitions to enhance hemogenic endothelial cell specification during hematopoiesis

MB Wilken, G Fonar, C Nations, G Pavani, V Tsao… - bioRxiv, 2023 - ncbi.nlm.nih.gov
… expressed in adherent cell types, including iPSC-derived mesoderm and endothelial cells,
but was … Targeted analysis of cells undergoing EHT revealed that TPM1 expression increased …

Krüppel-like factors in tumors: Key regulators and therapeutic avenues

Y Zhang, C Yao, Z Ju, D Jiao, D Hu, L Qi, S Liu… - Frontiers in …, 2023 - frontiersin.org
… as molecular targets in tumor … cells in TME play an essential role in tumor resistance and
metastasis. The proliferation and survival of natural killer cells, an important immune cell being …

[HTML][HTML] … in Second Line Large B Cell Lymphoma: Lessons from Phase 3 Trials–An Expert Panel Opinion from the American Society for Transplantation and Cellular …

MA Perales, LD Anderson Jr, T Jain… - … and cellular therapy, 2022 - ncbi.nlm.nih.gov
… and CAR T-cells recognizing alternative targets (eg CD22 or CD20) or dual targets, so clinical
… However, it is unclear if targeted therapies will lead to long term remissions in patients that …

NK 细胞免疫治疗恶性肿瘤的研究进展

曹腾宇, 孙莉萍, 于洋 - 临床输血与检验, 2024 - lcsxyjy.com
… , nature killer cells (NK cells), important to the body's natural … Like T cells, it can be engineered
to target tumor treatment, … high-dose autologous natural killer cell therapy with hepatic …